These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11167782)

  • 21. Evaluating viscoelastic properties and membrane electrical charges of red blood cells with optical tweezers and cationic quantum dots - applications to β-thalassemia intermedia hemoglobinopathy.
    Lima CN; Moura DS; Silva YSS; Souza TH; Crisafuli FAP; Silva DCN; Peres JC; Cesar CL; de Araujo RE; Fontes A
    Colloids Surf B Biointerfaces; 2020 Feb; 186():110671. PubMed ID: 31816460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deferiprone therapy in homozygous human beta-thalassemia removes erythrocyte membrane free iron and reduces KCl cotransport activity.
    de Franceschi L; Shalev O; Piga A; Collell M; Olivieri O; Corrocher R; Hebbel RP; Brugnara C
    J Lab Clin Med; 1999 Jan; 133(1):64-9. PubMed ID: 10385483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indices of membrane alterations in beta-thalassemic erythrocytes.
    Tavazzi D; Comino A; Turrini F; Fiorelli G; Cappellini MD
    Hemoglobin; 1998; 22(5-6):483-92. PubMed ID: 9859931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trial of deferiprone iron chelation therapy in beta-thalassaemia/haemoglobin E patients in Thailand.
    Pootrakul P; Sirankapracha P; Sankote J; Kachintorn U; Maungsub W; Sriphen K; Thakernpol K; Atisuk K; Fucharoen S; Chantraluksri U; Shalev O; Hoffbrand AV
    Br J Haematol; 2003 Jul; 122(2):305-10. PubMed ID: 12846901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of membrane peroxidation in thalassaemic erythrocytes by 2,3-dihydroxybenzoic acid.
    Graziano JH; Miller DR; Grady RW; Cerami A
    Br J Haematol; 1976 Mar; 32(3):351-6. PubMed ID: 1252369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
    Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
    Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of phospholipid membrane asymmetry and sialylated glycoconjugates from erythrocyte surface in haemoglobin E beta-thalassaemia.
    Basu S; Banerjee D; Chandra S; Chakrabarti A
    Br J Haematol; 2008 Apr; 141(1):92-9. PubMed ID: 18324971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.
    Walter PB; Fung EB; Killilea DW; Jiang Q; Hudes M; Madden J; Porter J; Evans P; Vichinsky E; Harmatz P
    Br J Haematol; 2006 Oct; 135(2):254-63. PubMed ID: 17010049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The labile iron pool in human erythroid cells.
    Prus E; Fibach E
    Br J Haematol; 2008 Jun; 142(2):301-7. PubMed ID: 18503586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha- and beta-haemoglobin chain induced changes in normal erythrocyte deformability: comparison to beta thalassaemia intermedia and Hb H disease.
    Scott MD; Rouyer-Fessard P; Ba MS; Lubin BH; Beuzard Y
    Br J Haematol; 1992 Apr; 80(4):519-26. PubMed ID: 1581237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative evaluation of oxidative stress status on peripheral blood in beta-thalassaemic patients by means of electron paramagnetic resonance spectroscopy.
    Filosa A; Valgimigli L; Pedulli GF; Sapone A; Maggio A; Renda D; Scazzone C; Malizia R; Pitrolo L; Lo Pinto C; Borsellino Z; Cuccia L; Capra M; Canistro D; Broccoli M; Soleti A; Paolini M
    Br J Haematol; 2005 Oct; 131(1):135-40. PubMed ID: 16173974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of iron chelators on labile iron and oxidative status of thalassaemic erythroid cells.
    Prus E; Fibach E
    Acta Haematol; 2010; 123(1):14-20. PubMed ID: 19923794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red cell deformability, splenic function and anaemia in thalassaemia.
    Dondorp AM; Chotivanich KT; Fucharoen S; Silamut K; Vreeken J; Kager PA; White NJ
    Br J Haematol; 1999 May; 105(2):505-8. PubMed ID: 10233428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-cell profiling of ineffective erythropoiesis in a mouse model of β-thalassaemia intermedia.
    Peng Y; Liang L; Zhang H; Liu H; Zhang G; Sun S; Guo X; Wang Y; Hu B; Liu R; Li Y; Nie L; Zhang J; Ye M; Ginzburg YZ; Lin Z; Yin B; Chen H; Liu J
    Br J Haematol; 2023 Jun; 201(5):982-994. PubMed ID: 36872867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased expression of membrane alpha4beta1, alpha5beta1 integrins and transferrin receptor on erythroblasts in splenectomized patients with beta-thalassemia intermedia. Parallel assessment of serum soluble transferrin receptors levels.
    Kossiva L; Paterakis G; Tassiopoulos S; Papadhimitriou SI; Voukouti E; Gligori I; Rombos Y
    Ann Hematol; 2003 Sep; 82(9):579-84. PubMed ID: 12904899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of deferiprone in patients with β-thalassaemia: impact of splenectomy and iron status.
    Limenta LM; Jirasomprasert T; Jittangprasert P; Wilairat P; Yamanont P; Chantharaksri U; Fucharoen S; Morales NP
    Clin Pharmacokinet; 2011 Jan; 50(1):41-50. PubMed ID: 21028920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Auto-oxidation and a membrane-associated 'Fenton reagent': a possible explanation for development of membrane lesions in sickle erythrocytes.
    Hebbel RP
    Clin Haematol; 1985 Feb; 14(1):129-40. PubMed ID: 2985310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of membrane-bound haemoglobin products in oxidative damage in sickle cell membranes.
    Rice-Evans C; Baysal E
    Acta Haematol; 1987; 78(2-3):105-8. PubMed ID: 3120454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased erythrocyte superoxide dismutase activities in beta 0-thalassaemia/haemoglobin E and in haemoglobin H diseases.
    Yenchitsomanus P; Wasi P
    J Clin Pathol; 1983 Mar; 36(3):329-33. PubMed ID: 6826781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of excess alpha-hemoglobin chains on cellular and membrane oxidation in model beta-thalassemic erythrocytes.
    Scott MD; van den Berg JJ; Repka T; Rouyer-Fessard P; Hebbel RP; Beuzard Y; Lubin BH
    J Clin Invest; 1993 Apr; 91(4):1706-12. PubMed ID: 7682576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.